What is the recommended dosage of midodrine (alpha-1 adrenergic receptor agonist) for orthostatic hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Midodrine Dosage for Orthostatic Hypotension

The recommended starting dose of midodrine is 10 mg three times daily, taken at approximately 4-hour intervals during daytime hours when the patient needs to be upright, with the last dose no later than 6 PM to avoid supine hypertension during sleep. 1

Standard Dosing Regimen

  • Start with 10 mg three times daily at 4-hour intervals: upon arising in the morning, midday, and late afternoon (not later than 6 PM) 1
  • Doses may be given at 3-hour intervals if needed to control symptoms, but not more frequently 1
  • Total daily doses should not exceed 30 mg (three 10 mg doses), as higher doses have not been systematically studied for safety 1

Dose Adjustments

For Renal Impairment

  • Begin with 2.5 mg doses in patients with abnormal renal function, as the active metabolite desglymidodrine is renally excreted 1
  • Midodrine is removed by hemodialysis; for dialysis patients, a single 5 mg dose given 30 minutes before dialysis improves intradialytic and postdialytic blood pressure 2

Higher Doses (Use with Caution)

  • Single doses up to 20 mg have been used, but severe supine hypertension occurs in approximately 45% of patients at this dose 1
  • The 20 mg dose produces similar standing blood pressure increases as 10 mg (about 30 mmHg at 1 hour) but with prolonged duration (4 hours vs 2 hours) and significantly higher risk of supine hypertension 1, 3

Critical Timing Considerations

  • Never administer after the evening meal or less than 4 hours before bedtime to reduce supine hypertension risk during sleep 1
  • The first dose should be taken shortly before or upon arising in the morning 1
  • Peak effect occurs at 1 hour post-dose, with some effect persisting for 2-3 hours after a 10 mg dose 1

Monitoring and Continuation Criteria

  • Monitor supine and standing blood pressure regularly and discontinue if supine blood pressure increases excessively 1
  • Continue midodrine only in patients who demonstrate symptomatic improvement during initial treatment 4, 1
  • The therapeutic goal is to minimize postural symptoms, not to restore normotension 5, 4

Evidence Supporting This Dosing

The 10 mg three times daily regimen is supported by multiple randomized controlled trials demonstrating:

  • Standing systolic blood pressure increases of 15-30 mmHg at 1 hour post-dose 1, 6
  • Significant improvement in orthostatic symptoms including dizziness, lightheadedness, weakness, and syncope 6, 7
  • A dose-response relationship showing 10 mg is effective while minimizing supine hypertension risk compared to 20 mg 3

Common Pitfalls to Avoid

  • Do not dose too late in the day: Evening doses cause nocturnal supine hypertension, which can lead to end-organ damage 5, 1
  • Do not start at full dose in renal impairment: The active metabolite accumulates, increasing adverse effect risk 1
  • Do not continue without documented benefit: Midodrine carries risks (supine hypertension, urinary retention) that only justify use when symptomatic improvement is clear 1

Non-Pharmacological Measures (Should Be Implemented Concurrently)

  • Increase fluid intake to 2-2.5 liters daily (unless contraindicated by heart failure) 2
  • Increase salt intake unless contraindicated 5, 2
  • Use compression garments over legs and abdomen 5, 2
  • Teach physical counter-pressure maneuvers (leg-crossing, squatting, muscle tensing) 5, 2
  • Elevate head of bed by 10 degrees during sleep 4

Side Effects

The most common adverse effects include:

  • Piloerection (goosebumps) and scalp pruritus/tingling (13.5% of patients) 2, 7
  • Supine hypertension (8% at 10 mg dose, 45% at 20 mg dose) 1, 7
  • Urinary retention or urgency (4%) 5, 7
  • Bradycardia and gastrointestinal symptoms 5

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.